Table 1.
Participant and disease characteristics
| Category | France | Germany | UK |
|---|---|---|---|
| (n = 159) | (n = 166) | (n = 159) | |
| (%) | (%) | (%) | |
| Gender | |||
| Female | 46.8 | 62.0 | 56.6 |
| Male | 53.2 | 38.0 | 43.4 |
| Age | |||
| < 45 years | 37.2 | 58.0 | 42.8 |
| 46–65 years of age | 44.2 | 32.9 | 37.0 |
| > 65 years | 18.6 | 9.1 | 20.2 |
| Primary cancer types | |||
| Breast | 36.1 | 23.2 | 36.5 |
| Lung | 20.9 | 20.7 | 13.2 |
| Prostate | 14.6 | 17.7 | 21.4 |
| Kidney | 8.2 | 7.9 | 4.4 |
| Colon | 6.3 | 7.9 | 5.0 |
| Thyroid | 2.5 | 4.3 | 5.0 |
| Melanoma | 1.9 | 4.3 | 3.1 |
| Other | 9.5 | 14.0 | 11.3 |
| Time since primary cancer diagnosis | |||
| < 2 years | 69.1 | 79.5 | 67.8 |
| Time since bone metastases diagnosis | |||
| < 1 year | 73.0 | 67.2 | 65.4 |
| Among those currently taking treatment to delay complications of bone metastases | 68.4 | 75.8 | 70.9 |
| Oral (pills or tablets) | 22.7 | 32.2 | 30.8 |
| Intravenously | 67.3 | 46.2 | 51.5 |
| Subcutaneously | 9.1 | 20.3 | 13.8 |
| Currently receiving chemotherapy | 73.0 | 68.5 | 53.5 |
| Among those currently receiving chemotherapy: How is chemotherapy given | |||
| Intravenously | 80.9 | 67.3 | 63.1 |
| Oral (pills and tablets) | 17.4 | 26.5 | 32.1 |
| Other | 1.7 | 6.2 | 4.8 |
| Losing ability to move around affected the patient the most in the past 2 weeks | 30.6 | 46.7 | 53.5 |
| Had a complication because of bone metastases | 50.9 | 57.4 | 59.5 |
| Severity of worst pain in the past week for any reason | |||
| No pain | 1.9 | 1.8 | 5.7 |
| Mild | 9.4 | 22.4 | 28.9 |
| Moderate | 45.3 | 50.3 | 44.7 |
| Severe | 43.4 | 25.5 | 20.8 |
| Severity of average pain in the past week for any reason | |||
| No pain | 2.5 | 3.0 | 6.3 |
| Mild | 19.0 | 29.9 | 32.3 |
| Moderate | 64.6 | 51.2 | 53.2 |
| Severe | 13.9 | 15.9 | 18.2 |